Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests
about
Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancerComparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder CancerQuantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method.Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cellsHigh VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer.Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.Clinical significance of serum and urinary HER2/neu protein levels in primary non-muscle invasive bladder cancerExtra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNOSIS.Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers.Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.Molecular markers in bladder cancer: Novel research frontiers.Molecular and Functional Diagnostic Tools in Precision Oncology for Urological Malignancies.Evaluation of double immunocytochemical staining for CK20 and P53 as a potential adjunct to cytology for urothelial cancer diagnosis.Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion.INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker.Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine.Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.Podoplanin serum and urine concentration in transitional bladder cancer.Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectives.Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer.Combined use of urinary Survivin detection and liquid-based cytology for the early diagnosis of bladder urothelial carcinoma.An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer
P2860
Q35051551-33FEA331-40B7-40AC-AF05-DCB5334CEBECQ35665449-7A279438-3DD5-46CC-8E1C-39C42914B016Q35730347-C3C058A6-6383-435C-BB96-9FE4C10854ADQ35926034-BFA41D84-3BE0-4676-B1CC-084F91DE7D97Q35934764-F0965FA8-25DE-4D8B-BAA0-920C4ECFB39FQ36556271-F4650201-06C8-44A4-B544-5D876B0C080EQ36589225-ABCE6CE5-7762-4D01-9C41-06CBD85960A9Q37419269-F9E5AB26-49E1-4E1A-865C-5C8C72AD2E14Q38188561-583A0459-247A-4909-9FD0-A7009C968A36Q38261250-9809702B-D046-4850-BE1E-6C4DE0496187Q38369215-E6816650-3BB8-4450-8058-CCBD9C437E9FQ38520403-0EB9DBB4-1F0B-4DC5-A0FA-118D5DD65D0FQ39105730-9342909C-5BF5-48E7-8082-4530E376E6D2Q39177122-AFC3F66D-1B83-4FA0-B175-705B62610226Q40324182-AC9472D7-E831-4AB4-9A23-69E1A198CE15Q43688428-528D2F37-231A-48EF-862E-9FAEACDCFD3DQ47834018-18841F8A-224A-4E86-84BC-747608F55DBEQ48097547-18763814-5060-4391-9F5C-8D6F9B9D3CE3Q48176407-595FD97E-A872-4D32-935C-6B4BDD411312Q48933536-C3ECEB92-59BB-4CC7-9B97-F9C8D7223D90Q49898696-47723D51-FE0C-49C8-A0FB-A9D61F2E4CE4Q50186828-D409B327-0ED0-45B9-8B7C-B5233C0CB060Q52620429-82CA3C58-FC67-4A2F-9326-220D523DC819Q55004870-75FBC5BF-5031-4813-80D1-719209A88F09Q55262997-CF5F854C-38D4-47CB-B7B8-EA11704E6602Q55425955-92A8C5A9-E15B-498D-BA65-5F30CB0F5EF2Q58714875-3BBBC08F-315A-4D9D-95B0-7AF277A507EC
P2860
Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Bladder cancer detection and m ...... - and blood-based marker tests
@ast
Bladder cancer detection and m ...... - and blood-based marker tests
@en
type
label
Bladder cancer detection and m ...... - and blood-based marker tests
@ast
Bladder cancer detection and m ...... - and blood-based marker tests
@en
prefLabel
Bladder cancer detection and m ...... - and blood-based marker tests
@ast
Bladder cancer detection and m ...... - and blood-based marker tests
@en
P2093
P2860
P1476
Bladder cancer detection and m ...... - and blood-based marker tests
@en
P2093
Charles J Rosser
Steve Goodison
Virginia Urquidi
P2860
P2888
P356
10.1007/S40291-013-0023-X
P577
2013-04-01T00:00:00Z